Brief: Idera Pharmaceuticals Files For Resale Of Up To 6.1 Million Shares By Selling Stockholder
02/06/2020 13:55
June 2 (Reuters) - Idera Pharmaceuticals Inc IDRA.O :
* IDERA PHARMACEUTICALS INC FILES FOR RESALE OF UP TO 6.1
MILLION
SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING
Source text: (https://bit.ly/36Vo8f6)
Further company coverage: IDRA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aceragen
See all newsBrief: Aceragen CEO John Taylor's Employment With Co Terminated
Brief: Aceragen Inc To Delist From The Nasdaq Stock Market
Aceragen Inc expected to post a loss of $1.20 a share - Earnings Preview
Brief: Aceragen Board Determined It Is In Best Interests Of Co,To Effect Transfer,Assignment Of All Of Co's Assets To Assignee
Aceragen Inc reports results for the quarter ended in March - Earnings Summary